Extended-spectrum β-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria

25Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

During a survey of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae in Bulgaria in 2001-2002, three isolates from Sofia (two Escherichia coli, one Klebsiella pneumoniae) showed cefotaxime MICs that were decreased in the presence of clavulanate and were 2-8-fold higher than those of ceftazidime. Resistance was transferred to a sensitive recipient strain of E. coli. Both wild-type and transconjugant strains produced a cefotaxime-hydrolysing β -lactamase of pI 8.8. Sequencing of the PCR product obtained with oligonucleotide primers binding outside the coding region identified this β-lactamase as CTX-M-15. To our knowledge, this is the first report of CTX-M-15 in Bulgaria. © 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases.

Cite

CITATION STYLE

APA

Markovska, R., Schneider, I., Keuleyan, E., & Bauernfeind, A. (2004). Extended-spectrum β-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria. Clinical Microbiology and Infection, 10(8), 752–755. https://doi.org/10.1111/j.1469-0691.2004.00929.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free